Correlation Between GlaxoSmithKline PLC and Standard Biotools
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Standard Biotools at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Standard Biotools into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Standard Biotools, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Standard Biotools and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Standard Biotools. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Standard Biotools.
Diversification Opportunities for GlaxoSmithKline PLC and Standard Biotools
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between GlaxoSmithKline and Standard is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Standard Biotools in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Standard Biotools and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Standard Biotools. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Standard Biotools has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Standard Biotools go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Standard Biotools
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Standard Biotools. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 3.9 times less risky than Standard Biotools. The stock trades about -0.3 of its potential returns per unit of risk. The Standard Biotools is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 175.00 in Standard Biotools on August 30, 2024 and sell it today you would earn a total of 7.00 from holding Standard Biotools or generate 4.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Standard Biotools
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Standard Biotools |
GlaxoSmithKline PLC and Standard Biotools Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Standard Biotools
The main advantage of trading using opposite GlaxoSmithKline PLC and Standard Biotools positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Standard Biotools can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Standard Biotools will offset losses from the drop in Standard Biotools' long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Standard Biotools vs. Star Equity Holdings | Standard Biotools vs. Biodesix | Standard Biotools vs. ENDRA Life Sciences | Standard Biotools vs. Fonar |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |